69 related articles for article (PubMed ID: 2889433)
1. Interaction of pathogenic and nonpathogenic Entamoeba histolytica with human complement.
Reed SL; Gault M; Gillin FD; Gigli I; Braude AI; Curd JG; Sargeaunt PG
Arch Invest Med (Mex); 1987; 18(2):141-9. PubMed ID: 2889433
[No Abstract] [Full Text] [Related]
2. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica.
Reed SL; Curd JG; Gigli I; Gillin FD; Braude AI
J Immunol; 1986 Mar; 136(6):2265-70. PubMed ID: 2869084
[TBL] [Abstract][Full Text] [Related]
3. [Activity of the alternative complement pathway by various axenic strains of Entamoeba histolytica].
Capin NR; Capin R; Zamacona G; Ortiz-Ortiz L
Arch Invest Med (Mex); 1978; 9 Suppl 1():291-6. PubMed ID: 211963
[TBL] [Abstract][Full Text] [Related]
4. Complement resistance of pathogenic Entamoeba histolytica mediated by trypsin-sensitive surface component(s).
Hamelmann C; Urban B; Foerster B; Horstmann RD
Infect Immun; 1993 May; 61(5):1636-40. PubMed ID: 8478051
[TBL] [Abstract][Full Text] [Related]
5. Extracts of airborne grain dusts activate alternative and classical complement pathways.
Olenchock SA; Mull JC; Major PC
Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
[TBL] [Abstract][Full Text] [Related]
6. Virulence of Entamoeba histolytica correlates with the capacity to develop complement resistance.
Mogyoros M; Calef E; Gitler C
Isr J Med Sci; 1986 Dec; 22(12):915-7. PubMed ID: 2883155
[No Abstract] [Full Text] [Related]
7. Lysozyme and complement-dependent lysis of Entamoeba histolytica. Inhibition by leupeptin.
Mogyoros M; Fishelson Z; Gitler C
Isr J Med Sci; 1986 Dec; 22(12):918-20. PubMed ID: 2883156
[No Abstract] [Full Text] [Related]
8. Entamoeba histolytica: an explanation for the reported conversion of "nonpathogenic" amebae to the "pathogenic" form.
Clark CG; Diamond LS
Exp Parasitol; 1993 Dec; 77(4):456-60. PubMed ID: 8253159
[TBL] [Abstract][Full Text] [Related]
9. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
10. Nonpathogenic Entamoeba dispar quickly outgrows pathogenic Entamoeba histolytica in mixed xenic cultures.
Pysova I; Tumova P; Tolarova V; Nohynkova E
Lett Appl Microbiol; 2009 Apr; 48(4):500-3. PubMed ID: 19187490
[TBL] [Abstract][Full Text] [Related]
11. Lysis of pathogenic and nonpathogenic Entamoeba histolytica by human complement: methodological analysis.
Hamelmann C; Foerster B; Burchard GD; Horstmann RD
Parasite Immunol; 1992 Jan; 14(1):23-35. PubMed ID: 1557228
[TBL] [Abstract][Full Text] [Related]
12. Activation of the alternative and classical complement pathways by Entamoeba histolytica.
Calderon J; Schreiber RD
Infect Immun; 1985 Nov; 50(2):560-5. PubMed ID: 2865212
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic versus nonpathogenic Entamoeba histolytica.
Mirelman D
Infect Agents Dis; 1992 Feb; 1(1):15-8. PubMed ID: 1365522
[No Abstract] [Full Text] [Related]
14. Extracts of wheat gluten activate complement via the alternative pathway.
Unsworth DJ; Würzner R; Brown DL; Lachmann PJ
Clin Exp Immunol; 1993 Dec; 94(3):539-43. PubMed ID: 8252813
[TBL] [Abstract][Full Text] [Related]
15. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of pathogenicity of Entamoeba histolytica by polymerase chain reaction].
Cheng XJ; Tachibana H; Kobayashi S; Kaneda Y; Huang MY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(3):172-5. PubMed ID: 8168237
[TBL] [Abstract][Full Text] [Related]
17. Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.
Ohta H; Yoshikawa Y; Kai C; Yamanouchi K; Okada H
Immunology; 1984 Jul; 52(3):437-44. PubMed ID: 6430791
[TBL] [Abstract][Full Text] [Related]
18. Chemotactic activity in periodontal disease. II. The generation of complement-derived chemotactic factors.
Okada H; Silverman MS
J Periodontal Res; 1979 Mar; 14(2):147-52. PubMed ID: 155734
[No Abstract] [Full Text] [Related]
19. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
Ferrante A; Rowan-Kelly B
Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
[TBL] [Abstract][Full Text] [Related]
20. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
